Description
BSE lists 4,48,889 equity shares of Vivo Bio tech Ltd. issued to promoters on preferential basis, effective August 8, 2025.
Summary
BSE has approved the listing of 4,48,889 new equity shares of Vivo Bio tech Ltd. (Scrip Code: 511509) issued to promoters on a preferential basis pursuant to warrant conversion. The shares will commence trading on August 8, 2025, and are subject to a lock-in period until February 28, 2027.
Key Points
- 4,48,889 equity shares of Rs. 10/- each issued at premium of Rs. 35/-
- Issue price: Rs. 45/- per share
- Issued to promoters on preferential basis through warrant conversion
- Shares rank pari-passu with existing equity shares
- Distribution numbers: 17475928 to 17924816
- Date of allotment: April 17, 2025
- ISIN: INE380K01017
Regulatory Changes
No regulatory changes introduced. Standard listing procedure for preferentially allotted shares.
Compliance Requirements
- Trading members must note the new securities for trading purposes
- Lock-in compliance must be maintained until February 28, 2027
- Shares subject to standard listing agreement obligations
Important Dates
- August 8, 2025: Trading commencement date
- April 17, 2025: Date of allotment
- February 28, 2027: Lock-in period expiry
Impact Assessment
Minimal market impact expected as shares are issued to promoters and subject to lock-in restrictions until February 2027. The preferential allotment increases the company’s equity base by approximately 4.49 lakh shares without immediate trading pressure due to lock-in provisions.
Impact Justification
Standard new share listing with limited market impact due to promoter allotment and lock-in period